- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sagimet Biosciences Inc (SGMT)
Sagimet Biosciences Inc stock price live, this page displays NASDAQ SGMT stock exchange data. View the SGMT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sagimet Biosciences Inc real time stock price chart below.
What Is the Sagimet Biosciences Inc Stock Price Today?
The Sagimet Biosciences Inc stock price today is 8.450.
What Is the Stock Symbol for Sagimet Biosciences Inc?
The stock symbol for Sagimet Biosciences Inc is ""SGMT.""
What Stock Exchange Does Sagimet Biosciences Inc Trade On?
Sagimet Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Sagimet Biosciences Inc a Good Stock to Buy?
Determining whether Sagimet Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SGMT quote. (ISIN: US7867001049)
What Is the Sagimet Biosciences Inc Stock Price Today?
The Sagimet Biosciences Inc stock price today is 8.450.
What Is the Stock Symbol for Sagimet Biosciences Inc?
The stock symbol for Sagimet Biosciences Inc is ""SGMT.""
What Stock Exchange Does Sagimet Biosciences Inc Trade On?
Sagimet Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Sagimet Biosciences Inc a Good Stock to Buy?
Determining whether Sagimet Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SGMT quote. (ISIN: US7867001049)
NASDAQ
Currency in USD
8.450
+0.200(+2.42%)
Closed·
After Hours
8.730+0.280(+3.31%)
·
Fair Value
An estimate of a Sagimet Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.270
8.690
52 wk Range
1.730
11.410
SGMT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
SGMT is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Sagimet Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.2708.690
52 wk Range
1.73011.410
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SGMT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Sagimet Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
21.857
Upside
+158.66%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
6 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Sagimet Biosciences Inc Company Profile
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States. The company’s lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis. It also develops TVB-3567, a FASN inhibitor for the treatment of acne; and other oncology programs, such as various solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
Sagimet Biosciences Inc SWOT Analysis
MASH Market Promise | Explore denifanstat's potential as a breakthrough oral treatment for nonalcoholic steatohepatitis, positioning Sagimet Biosciences in a competitive landscape |
Financial Tightrope | Delve into Sagimet's financial strategy, balancing a strong cash position against the need for additional funding to advance clinical trials |
Pipeline Expansion | Learn about Sagimet's diversification efforts, including combination therapies and expansion into acne treatment, to broaden its market potential |
Analyst Optimism | Discover why analysts maintain a bullish outlook on Sagimet, with price targets ranging from $5 to $67, despite development timeline challenges |
Compare SGMT to Peers and Sector
Metrics to compare | SGMT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSGMTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.8x | −1.4x | −0.5x | |
PEG Ratio | 0.37 | −0.03 | 0.00 | |
Price/Book | 2.0x | 0.8x | 2.6x | |
Price / LTM Sales | - | 41.6x | 3.3x | |
Upside (Analyst Target) | 215.2% | 451.3% | 45.1% | |
Fair Value Upside | Unlock | 31.5% | 7.4% | Unlock |
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 21.857
(+158.66% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-0.56 / -0.71
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Sagimet Biosciences Trade On?
Sagimet Biosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Sagimet Biosciences?
The stock symbol for Sagimet Biosciences is "SGMT."
What Is the Sagimet Biosciences Market Cap?
As of today, Sagimet Biosciences market cap is 265.61M.
What Is Sagimet Biosciences's Earnings Per Share (TTM)?
The Sagimet Biosciences EPS (TTM) is -1.78.
When Is the Next Sagimet Biosciences Earnings Date?
Sagimet Biosciences will release its next earnings report on 24 Aug 2025.
From a Technical Analysis Perspective, Is SGMT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Sagimet Biosciences Stock Split?
Sagimet Biosciences has split 0 times.
How Many Employees Does Sagimet Biosciences Have?
Sagimet Biosciences has 14 employees.
What is the current trading status of Sagimet Biosciences (SGMT)?
As of 04 Aug 2025, Sagimet Biosciences (SGMT) is trading at a price of 8.45, with a previous close of 8.25. The stock has fluctuated within a day range of 8.27 to 8.69, while its 52-week range spans from 1.73 to 11.41.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.